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Original article
Is it possible to identify individuals with mild cognitive impairment and Alzheimer’s 
disease using a 30-minute neuropsychological battery?
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Abstract
Background: Distinguishing individuals with dementia from those with mild cognitive impairment (MCI) might demand a neuropsychological evaluation. 
Methods: One hundred and thirty-one consecutive referred elderly patients (37 clinical-controls, 41 with amnestic MCI and 53 with possible/probable AD) 
were diagnosed with a comprehensive (full) neuropsychological battery, MRI and clinical data. All of the results were blindly coded and evaluated latter with 
a subset of the tests to reclassify the subjects as MCI, dementia or clinical-control. Agreement rates between both batteries were calculated. We also used 
ROC curves to establish the sensitivity and specificity of the brief battery for discriminating (i) clinical-control individuals from a group dementia and MCI 
patients; (ii) individuals with dementia from individuals without dementia; (iii) clinical-control individuals from a group of MCI. We compared performance 
of the three groups on all full battery tasks. Results: All neuropsychological tests showed differences between clinical-control and dementia groups. The com-
parison between MCI and the other groups mainly showed memory differences. Agreement between brief and full batteries was substantial (kappa = 0.805). 
Analyses with ROC curves showed good sensitivity and specificity to discriminate non-demented (clinical control plus MCI groups) and AD group and also 
to discriminate clinical-control individuals from individuals with cognitive decline (MCI plus AD group). However, sensitivity and specificity significantly 
decreased when brief battery was tested to discriminate only normal and MCI diagnosis. Discussion: The use of a brief battery might not be indicated to 
discriminate MCI and clinical-control individuals, but its use might be adequate to discriminate less specific groups (demented versus non-demented and 
pathological [dementia and MCI] and non-pathological [clinical-control] groups). 
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Resumo
Contexto: A diferenciação de pacientes com diagnósticos de demência e de comprometimento cognitivo leve (CCL) pode exigir avaliação neuropsicológica. 
Métodos: Cento e trinta e um pacientes idosos consecutivos referidos para avaliação (37 controles-clínicos, 41 com CCL amnéstico e 53 com DA possível/
provável) foram diagnosticados com bateria neuropsicológica completa, RM e dados clínicos. Todos os resultados foram codificados de forma cega e poste-
riormente avaliados com parte dos testes para reclassificar indivíduos com CCL, demência ou controles-clínicos. Concordância entre as baterias foi calculada. 
Utilizamos curvas ROC para estabelecer sensibilidade e especificidade da bateria breve para discriminar: (i) controles-clínicos de um grupo de demência e 
CCL; (ii) indivíduos com demência daqueles indivíduos sem demência; (iii) controles clínicos daqueles indivíduos com diagnóstico de CCL. Comparamos o 
desempenho dos três grupos em todas as tarefas da bateria completa. Resultados: Todos os testes neuropsicológicos mostraram diferenças entre controles-
-clínicos e grupo de demência. A comparação entre CCL e outros grupos mostrou, principalmente, diferenças em tarefas de memória. Concordância entre 
baterias breve e completa foi substancial (kappa = 0.805). Análises com curvas ROC demonstraram boas sensibilidade e especificidade quando comparados 
grupos de indivíduos com demência e sem demência (grupos de CCL e DA agrupados) e grupos de controle-clínico de indivíduos com declínio cognitivo 
(CCL associado à DA). Por outro lado, sensibilidade e especificidade diminuíram consideravelmente para discriminar controles-clínicos de indivíduos com 
diagnóstico de CCL. Conclusão: O uso de bateria breve pode não ser recomendado para discriminar controles-clínicos de indivíduos com CCL, porém o 
uso pode estar indicado para diferenciar grupos de especificidade menor [demência versus não demência ou grupos patológicos (demência e CCL) de grupo 
não patológicos (controles clínicos)]. 
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Introduction
Many studies of mild cognitive impairment (MCI) in the last 
decade have sought to elucidate clinical, neuropsychological and 
neuroimaging aspects1. MCI diagnosis is associated with elevated 
rates of conversion to AD2. The use of screening tests only, such 
as the MMSE, is not recommended due to the lack of specificity, 
sensitivity, or both3. To identify individuals at risk for Alzheimer’s 
disease (AD) or other dementias, appropriate neuropsychological 
tools to detect MCI are needed. There is no consensus, however, on 
which tests should be part of such an evaluation. It should also be 
considered that early treatment with cholinesterase inhibitors may 
benefit MCI individuals4.
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Most studies focus on the amnestic subtype of MCI, single or 
multiple-domain5, as the best predictor of AD, which is the most 
prevalent dementia in the elderly6, which associate with significant 
impact even in initial in mild phase7. It should be noted that there 
is no consensus on the definition of impairment in non-memory 
functions, an aspect that may jeopardize the recognition of non-
-amnestic MCI.
Some studies in Brazil have proposed new neuropsychological 
batteries and brief screening tools for the diagnosis of both MCI and 
dementia8-11. Some studies have investigated single tests or existing 
batteries, such as the Clock Drawing Test (CDT)12, the Mini-Mental 
State Examination (MMSE) and the Cambridge Mental Disorders 
of the Elderly Examination (CAMDEX). Diniz et al.9 compared a 
brief screening and a neuropsychological battery, demonstrating 
that both could discriminate MCI from dementia (although they 
failed to discriminate among different types of MCI). Using a diffe-
rent design, Paula et al.13 evaluated a brief screening for a geriatric 
population that used tasks considered fast and easy to administrate. 
That study demonstrated the importance of evaluating cognition 
in elderly populations using batteries with good construction and 
valid criteria. Ladeira et al.14 showed that a combination of screening 
tools, such as the MMSE, verbal fluency and CDT, was not useful for 
identifying cases of AD or MCI.
The studies conducted by both Paula et al.13 and Ladeira et al.14 did 
not include memory tasks. Diniz et al.9 included a very short memory 
task that did not evaluate either retention over time or delayed recall. 
The use of batteries without memory tasks – or without memory tasks 
evaluating retention over time – has a greater likelihood of failure in 
identifying cases of amnestic MCI (single domain) where memory 
deficits are not accompanied by other cognitive impairments.
Comprehensive neuropsychological batteries have the obvious 
advantage of greater sensitivity to brain injury or dysfunction of 
any etiology, but at the expense of time and cost. Shorter batteries 
might also prove useful for research purposes and, to some extent, for 
clinical practice as well, particularly where a full neuropsychological 
examination is not immediately available or feasible. The need for 
consensus on a diagnostic battery for MCI motivated the current 
study. We aimed to develop a brief neuropsychological battery (las-
ting up to 30 minutes) to discriminate among normal aging, MCI 
and dementia. Based on the literature review, we hypothesized that a 
30-minute battery would be suitable to discriminate the three groups 
with good sensitivity and specificity.
Methods
One hundred and thirty-one elderly patients (37 controls, 41 MCI 
and 53 possible or probable AD) were consecutively referred for 
neuropsychological evaluation in a private clinic. All patients were 
referred by their physicians because of memory complaints to dis-
criminate among normal aging, MCI or dementia. The demographic 
profile of the patients is shown in table 1. This study was approved by 
the Ethics Committee of D’Or Institute for Research and Education; 
being a retrospective survey of clinical files, patients did not sign an 
informed consent, in accordance to Brazilian regulations.
Categorical (“golden standard”) diagnoses. Diagnoses were made 
by consensus by a trained, board-certified neuropsychologist (GC) 
and a board-certified psychiatrist (PM), considering DSM-IV crite-
ria, neuroimaging (MRI), clinical data and the neuropsychological 
results from the full battery. AD diagnoses were made based on 
NINCDS-ADRDA criteria15. MCI diagnoses were made according 
to the definitions proposed by Winblad et al.16, but restricted to 
amnestic subtype, since we aimed to study individuals at higher 
risks of developing AD: memory complaints; not demented but also 
not normal for age; cognitive decline; essentially normal functional 
activities of daily living. The classification of MCI was determined 
by a consensus by the aforementioned researchers (PM and GC) 
based on clinical data and neuropsychological results from the 
full battery. After clinical data were collected (present complaints, 
collateral reports, premorbid history, family history, medication), all 
individuals underwent a comprehensive evaluation that included the 
following test battery: Logical Memory from WMS-III, the Brazilian 
version of RAVLT17-18, Family Pictures, Digit Span, Spatial Span, 
CDT, MMSE, Vocabulary from WAIS-III, Matrix Reasoning from 
WAIS-III, and verbal fluency, both semantic (animals and fruits) and 
letter (F, A, and S). Participants were also evaluated with the Geriatric 
Depression Scale (GDS)19 and the Memory Assessment Complaints 
Questionnaire (MAC-Q)20. Daily activities were investigated with 
Pfeffer Functional Activities Questionnaire21. The questionnaire was 
filled out by a close relative or caregiver.
Brief neuropsychological battery. The results for all patients 
were blindly coded and evaluated a second time with a subset of 
the tests used in the full battery. The results of performance on the 
brief battery were used to make a categorical diagnosis of “normal”, 
“MCI”, or “dementia” based on the judgment of the authors who 
determined categorical diagnoses. In this step, the clinicians only 
considered neuropsychological results. The diagnoses generated by 
a brief battery were then compared to the golden standard diagnoses, 
as explained above. The tests in the brief battery were chosen based 
on the following criteria: a) a short time should be required to ad-
minister the tasks; b) there should be extensive neuropsychological 
data in the literature about the test structure and its interpretation; 
c) there should be normative data for each test – it must be highli-
ghted that some of the used tasks do not have available Brazilian 
normative groups; d) there should be a memory task that evaluate 
both immediate and delayed recall, but other cognitive domains 
should be covered as well; and e) the tests should be either the ones 
used in the original MCI studies or structurally equivalent to them. 
The following tests complied with these criteria: the verbal memory 
task from the original MCI studies (i.e., Logical Memory from 
WMS22), the semantic (animals) fluency test, the auditory working 
memory test (Digit Span, comprising measures of the phonological 
loop and central executive functions), constructional praxis and 
executive functioning (CDT), and the MMSE. Tests of brief and full 
battery are listed in table 2.
Agreement rates between the full (comprehensive) and brief 
batteries were calculated with the kappa statistics with quadratic wei-
ghting by considering three categorical diagnoses (dementia, MCI, 
and normal). Two analyses were then performed, both comparing 
the brief and the comprehensive batteries, but considering only two 
groups for each analysis (described below). These analyses used ROC 
curves to establish the sensitivity and specificity of the brief battery 
in discriminating (i) normal individuals from a group of demented 
and MCI patients (i.e., “normal” versus “pathologic”; (ii) individuals 
with dementia from individuals without dementia, the latter group 
comprising normal and MCI subjects; and (iii) normal individuals 
from MCI group. We also compared the performance of the three 
Table 1. Demographic variables across diagnostic (gold standard) categories
AD MCI Controls Contrasts
N 53 41 37
Age (years) 75.25 (±7.41) 73.76 (±7.01) 72.08 (±6.86) P = 0.120 1=2=3
Gender (women/men) 30/23 23/18 28/9 P = 0.123
Education (years) 10.88 (±4.5) 13.02 (±4.13) 14.56 (±5.25) P = 0.003 3>1; 3>2; 1=2
Statistical analysis: Age – One-way ANOVA with post-hoc Bonferroni test. Gender – Pearson chi-Square. Education – Kruskal-Wallis test.
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Table 2. Tests from the full and brief battery
Full battery Brief battery
Logical Memory Logical Memory
Clock Drawing Test Clock Drawing Test
Digit Span Digit Span
Fluency Animals Fluency Animals
Fluency Fruits MEEM
Fluency F
Fluency A
Fluency S
MEEM
RAVLT
Family Pictures
Vocabulary
Matrix
groups on all tasks of the full battery. Because most measures did 
not have a normal distribution, comparisons were performed using 
the Kruskal-Wallis test, and contrasts were performed using the 
Mann-Whitney with the post-hoc Bonferroni test. Comparisons of 
age were made with ANOVA, and the Kruskal-Wallis test was used 
for comparisons of educational level. The gender distribution was 
calculated with Pearson’s chi-square test (χ²).
Results
The three groups did not differ in age. The normal group had more 
years of education than the AD group (p = 0.003), but the normal 
and MCI groups did not differ in terms of education. Gender dis-
tribution did not differ across groups. The AD group comprised 53 
individuals, whereas the MCI and control groups comprised 41 and 
37 individuals, respectively. The results are summarized in table 1.
All neuropsychological tests showed significant differences be-
tween the normal and AD groups. When comparing the normal and 
MCI groups, memory tests (RAVLT A1, RAVLT A5, Family Pictures 
and Logical Memory [both immediate and delayed recall]), MEEM 
and semantic verbal fluency (a animals and fruits) reached signifi-
cance. When comparing the MCI and AD groups, only the forward 
Digit Span did not reach significance. The results of the comparisons 
are summarized in table 3.
Table 3. Neuropsychological measures and mean results
Normal
N = 37 (28.2%)
MCI
N = 41 (31.2%)
AD
N = 53 (40.6%)
H Contrasts
Logical Memory 1
Logical Memory 2
Clock Test
Span F
Span B
Fluency Ani
Fluency Fru
Fluency F
Fluency A
Fluency S
MEEM
RAVLT A1
RAVLT A5
RAVLT A7/A6
RAVLT R
Family Pictures 1
Family Pictures 2
Vocabulary
Matrix
33.05 ± 9.42
21.00 ± 6.55
9.70 ± 1.13
5.27 ± 0.99
3.94 ± 1.05
16.62 ± 4.38
14.75 ± 4.34
12.35 ± 5.05
10.78 ± 4.09
11.48 ± 4.70
27.16 ± 1.80
5.40 ± 1.78
11.16 ± 2.10
1.09 ± 0.27
11.08 ± 4.11
28.46 ± 10.88
27.27 ± 9.38
43.84 ± 8.90
11.67 ± 5.20
23.56 ± 8.68
11.03 ± 4.06
9.05 ± 2.14
5.31 ± 1.27
3.92 ± 1.12
13.24 ± 4.28
12.09 ± 3.62
11.95 ± 5.51
11.73 ± 5.46
10.70 ± 4.58
25.53 ± 2.14
4.29 ± 1.27
8.63 ± 1.95
0.94 ± 0.51
7.27 ± 6.49
15.78 ± 9.31
15.85 ± 9.30
40.00 ± 11.75
10.63 ± 5.91
13.64 ± 7.47
4.80 ± 5.94
8.00 ± 2.87
4.83 ± 0.89
3.22 ± 0.80
9.30 ± 4.13
9.28 ± 3.19
7.52 ± 3.89
6.66 ± 3.74
7.57 ± 4.15
21.64 ± 3.75
3.20 ± 1.58
6.32 ± 2.25
0.70 ± 0.79
1.79 ± 8.07
13.49 ± 6.40
13.13 ± 7.13
32.19 ± 13.16
6.45 ± 3.68
61.80*
81.87*
16.35*
6.78
15.45*
48.93*
38.51*
25.59*
29.67*
18.01*
61.05*
29.67*
61.98*
19.22*
34.31*
38.23*
41.99*
19.09*
28.11*
1>2>3
1>2>3
1=2>3
1=2=3
1=2>3
1>2>3
1>2>3
1=2>3
1=2>3
1=2>3
1>2>3
1>2>3
1>2>3
1=2>3
1=2>3
1>2>3
1>2>3
1=2>3
1=2>3
* p-values ≤ 0.05, two-tailed contrast was performed using the Mann-Whitney (with post-hoc Bonferroni) test.
We also assessed the combination of the tests used to compose 
the brief battery. The agreement between the full battery and the brief 
battery was considered substantial (kappa = 0.805) according to the 
reliability patterns proposed by Shrout and Fleiss23. When the MCI 
and AD cases were sorted in the same group, the brief battery had 
good sensitivity (78.4%) and specificity (89.4%) for discriminating 
patients (MCI plus AD) from normal cases [area under the curve 
(auc) = 0.84]. The positive and negative predictive values were 74.4% 
and 91.3%, respectively. When the MCI and normal cases were sorted 
in the same group, the brief battery had good sensitivity (83.3%) 
and specificity (90.6%) for discriminating non-demented (MCI plus 
normal) from AD patients (auc = 0.87). The positive and negative 
predictive values were 92.9% and 78.7%, respectively. We performed 
an additional analysis, this time comparing only MCI and normal 
groups – excluding all individuals that received a diagnosis of AD 
from either battery –; the comparisons were made considering 28 
MCI and 37 normal individuals. In this case, both sensitivity and 
specificity decreased (64.28% and 78.37%, respectively; auc = 0.71). 
The positive and negative predictive values were 69.2% and 74.4%, 
respectively.
Discussion
Normal individuals had more years of education in comparison to 
the other groups, a result previously identified in other studies6. The 
groups did not differ in terms of age (Table 1) or gender distribution 
The latter two findings are not in accordance with the findings of 
other studies, which highlight age and gender (female) as two of the 
most important risk factors for developing AD24. This discrepancy 
may be secondary to a referral bias because we evaluated a sample of 
patients referred to a private unit for neuropsychological evaluation 
of memory problems, which occur in a wider age range of individuals 
in clinical practice, from adulthood to old age. 
Most of the studies on MCI have considered only amnestic 
subtypes, including both single and multiple domains25. The study 
conducted by Diniz et al.9 found that amnestic subtypes of MCI were 
the most common in their sample, corresponding to approximately 
two-thirds of MCI cases. One possible explanation is that AD is the 
most common type of dementia; thus, samples comprising individu-
als with cognitive decline without dementia are expected to include 
primarily amnestic subtypes of MCI. For this reason, we developed a 
brief battery that used an episodic memory task allowing us to assess 
immediate and delayed recall. Therefore, our MCI individuals are 
amnestic (both single and multiple domains). 
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The performances in the three groups showed discrepancies in 
most of the measures, except for the Digit Span and the CDT. Despite 
its failure to discriminate normal individuals from MCI individuals, 
the CDT discriminated MCI from AD. This result could be explained 
by the fact that CDT is a task that aims to evaluate executive functions 
and constructional praxis, which are not expected to be impaired 
in the amnestic forms of MCI but are often impaired in AD12. In 
addition, the CDT is often used to support an AD diagnosis in the 
literature. We found it to be important even though it does not help 
to discriminate normal individuals from those with MCI.
Digit Span forward performances did not differ among the three 
groups, indicating that there were no differences in the phonological 
loop. In fact, Digit Span does not process semantic information26 
and is generally intact at the preclinical and early stages of AD27. 
Performances on the Digit Span backward (the second step of the 
Digit Span, in which digits are repeated in the reverse order) were 
similar in comparisons of normal and MCI individuals, whereas 
individuals with AD were significantly impaired compared to the 
non-demented groups. The Digit Span test is a measure of central 
executive function26; it is expected that amnestic type (single domain) 
of MCI do not involve difficulties with this function.
All of the other measures of the brief battery (i.e., Logical Me-
mory I and II, verbal fluency (animals), and MMSE) were signifi-
cantly different between normal and MCI patients as well as between 
MCI and AD patients.
We also performed a post-hoc analysis of the tests used to com-
pose the brief battery. The agreement between full and brief batteries 
had a kappa of 0.805. This finding suggests that, at least for samples 
including individuals with cognitive decline marked by memory defi-
cits, the brief battery might be applied. When grouping MCI and AD 
cases in the same group and comparing the sensitivity and specificity 
of the brief battery in discriminating those groups, we found good 
sensitivity and specificity (78.38% and 89.36%, respectively). The 
AUC was 0.839, suggesting that this brief battery might also be useful 
in discriminating normal and pathological aging. When grouping 
MCI and normal individuals in the same group and comparing their 
performance to that of AD individuals, we found good sensitivity 
and specificity (83.33% and 90.57%, respectively), suggesting that 
this battery might be useful to discriminate individuals with AD 
from normal individuals. 
Contrarily to our expectations, both sensitivity and specificity of 
brief battery significantly decreased (64.28% and 78.37%, respective-
ly) when we compared only groups of MCI and normal individuals. 
Additionally, positive and negative predictive values were 69.2% 
and 74.4%, respectively, which indicates that this brief battery might 
not be recommended to discriminate MCI and normal individuals.
Controversially to our results, another study conducted in Bra-
zil8 showed that brief batteries could accurately discriminate MCI 
from normal and demented individuals, although not sensitively 
enough to establish subtypes of MCI (e.g., amnestic, non-amnestic 
or multiple domain). Our findings suggest that, at least in a sample 
that mirror clinical everyday clinical practice (i.e., clinical-control 
individuals, MCI and individuals with dementia), the use of this 
brief battery should be restricted to the purpose of determining 
less specific groups, such as: 1) individuals with no decline versus 
individuals with cognitive decline (normal versus MCI plus AD); 
or 2) individuals without AD (MCI plus normal individuals) from 
individuals with AD. 
Conclusion
It should be stressed that the proposed brief battery alone does not 
provide an MCI diagnosis per se, which requires clinical evaluation 
by the physician. The use of a brief battery with both immediate and 
delayed recall might not be recommend for clinicians with the aim 
of discriminating MCI from normal aging. Furthermore, it should 
be noted that for the purposes of an individual evaluation, there is 
a paucity of adequate normative data in our country, which is well 
known for the enormous heterogeneity of the population in diffe-
rent regions. For this reason, we selected tests with normative data, 
extensive data, or both because future studies may provide specific 
norms for the proposed brief battery.
Despite good agreement rates between the full battery and the 
brief battery ((kappa = 0.805), several diagnoses using our gold stan-
dard changed when using the brief battery, which is critical from the 
perspective of individual cases. For example, 13 MCI subjects were 
incorrectly classified as having dementia, whereas 5 individuals with 
dementia were reclassified as MCI.
The brief battery demonstrated good sensitivity and specificity for 
two specific purposes: 1) the discrimination of individuals without 
significant cognitive decline versus individuals with significant cogni-
tive decline (normal versus MCI plus AD); and 2) the discrimination 
of AD from non-AD groups (MCI plus normal individuals). 
Limitations
This study should be understood in light of some limitations. Our 
dementia group could be heterogeneous regarding the severity of 
the cognitive deficit because we used categorical diagnoses but not 
severity scales. Because our study was focused in individuals with 
memory complaints (following other studies comprising amnestic 
MCI), we do not know whether our brief battery might be helpful in 
diagnosing non-amnestic MCI or non-Alzheimer dementias. For the 
same reason, the value of our brief battery in the ancillary diagnosis 
of dementias associated with behavioral changes or psychopatholo-
gical symptoms remains to be demonstrated. Moreover, despite the 
good statistical agreement between both batteries, its use should be 
restricted to the aforementioned conditions.
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